CERRONE GABRIELE M (CIK 1139306) reported 18 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-08-07). Recent activity: Buy TLSA (42,357 shares), Buy TLSA (15,000 shares), Buy OKYO (22,500 shares), Buy OKYO (25,000 shares), Buy TLSA (42,357 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Tiziana Life Sciences Ltd (TLSA) | Director | Buy | 42,357 | $41,933 |
| 2026-08-07 | Tiziana Life Sciences Ltd (TLSA) | Director | Buy | 15,000 | $16,650 |
| 2026-08-07 | OKYO Pharma Ltd (OKYO) | Director | Buy | 22,500 | $32,625 |
| 2026-08-07 | OKYO Pharma Ltd (OKYO) | Director | Buy | 25,000 | $35,000 |
| 2026-07-23 | Tiziana Life Sciences Ltd (TLSA) | Director | Buy | 42,357 | $41,933 |
| 2026-07-23 | OKYO Pharma Ltd (OKYO) | Director | Buy | 22,500 | $32,625 |
| 2026-07-21 | OKYO Pharma Ltd (OKYO) | Director | Buy | 25,000 | $35,000 |
| 2026-06-17 | Tiziana Life Sciences Ltd (TLSA) | Director | Buy | 15,000 | $16,650 |
| 2026-06-10 | OKYO Pharma Ltd (OKYO) | Director | Buy | 300,000 | $516,000 |
| 2025-06-16 | Accustem Sciences Inc. (ACUT) | Director | Buy | 2,000 | $2,000 |
| 2025-06-16 | Accustem Sciences Inc. (ACUT) | Director | Buy | 400 | $440 |
| 2025-06-13 | Accustem Sciences Inc. (ACUT) | Director | Buy | 28,205 | $11,000 |
| 2025-06-13 | Accustem Sciences Inc. (ACUT) | Director | Buy | 8,991 | $7,463 |
| 2025-04-10 | Accustem Sciences Inc. (ACUT) | Director | Buy | 35,000 | $23,450 |
| 2025-04-10 | Accustem Sciences Inc. (ACUT) | Director | Buy | 3,000 | $2,010 |
| 2025-04-08 | Accustem Sciences Inc. (ACUT) | Director | Buy | 100,000 | $45,000 |
| 2025-04-08 | Accustem Sciences Inc. (ACUT) | Director | Buy | 17,802 | $10,859 |
| 2025-04-08 | Accustem Sciences Inc. (ACUT) | Director | Buy | 35,000 | $22,750 |
Source: SEC Form 4 filings · as of 2026-08-07